<DOC>
	<DOCNO>NCT01735253</DOCNO>
	<brief_summary>Surgical treatment type 2 diabetes take note especially less obese non obese patient . In Asian , nuber less ob non obese patient T2DM great obese . We try prospective observational study evaluation effect duidenojejunal bypass gastric bypass glycemoc control patient . The selection criterion type 2 diabetes , 20-60 year old , BMI 23-34 21-22 viceral obesity , insulin use less 10 year patient understand hypothesis study , risk , expect effect agree study . We check oral GTT , insulin level , C-peptide level , HbA1C , etc . anthropometric measurs preoperatively , postoperatively , 3 month 12 month . We compare clinical factor time .</brief_summary>
	<brief_title>Prospective Observatonal Study Effect Duodenojejunal Bypass Gastric Bypass T2DM Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>type 2 diabetes HbA1C &gt; 7.0 % BMI 23 34 BMI 2122 viceral obesity insulin use less 10 year uncerstanding risk , hypothesis , expect effect type 1 diabetes Cpeptide &lt; 1.0ng/ml BMI &lt; 21 severe cardiovascular disease history malignancy history alcoholic , pituitary failrue history severe ketosis , diabetic coma precoma abnormal liver enzyme , 3 fold normal level liver cirrhosis hepatitis serum creatinine &gt; 2.0mg/dL glucocorticoid user diabetes due endocrine diseases pancreatic disease antiGAD Ab ( + ) incongruity surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>metabolic surgery</keyword>
	<keyword>gastric bypass</keyword>
	<keyword>duodenojejunal bypass</keyword>
	<keyword>type 2 DM</keyword>
</DOC>